Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer.

NCT01789099 is registered in ClinicalTrials.gov with Ultimovacs ASA as lead sponsor.

NCT NCT01789099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01789099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer.
Lead sponsor
Ultimovacs ASA
Phase
Phase 1/2
Overall status
Completed
Start date
April 8, 2013
Completion date
June 12, 2020
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer